Inozyme Pharma, Inc. (INZY)

Inozyme Pharma Market Cap

Inozyme Pharma has a market cap or net worth of $284.84 million as of May 17, 2024. Its market cap has increased by 0.44% in one year.

• Market Cap: 284.84M
• Enterprise Value: 165.02M
• 1-Year Change: 0.44%
• Ranking: #3406
• Category: Micro-Cap
• Stock Price: $4.60

Market Cap Chart

Since July 24, 2020, Inozyme Pharma's market cap has decreased from $382.60M to $284.84M, a decrease of -25.55%. That is a compound annual growth rate of -7.44%.

Market Cap History

Date	Market Cap	% Change
May 17, 2024	284.50M	-2.77%
May 16, 2024	292.60M	1.28%
May 15, 2024	288.90M	0.87%
May 14, 2024	286.40M	2.65%
May 13, 2024	279.00M	-0.64%
May 10, 2024	280.80M	-2.36%
May 9, 2024	287.60M	0.21%
May 8, 2024	287.00M	0.88%
May 7, 2024	284.50M	-5.61%
May 6, 2024	301.40M	2.94%
May 3, 2024	292.80M	1.95%
May 2, 2024	287.20M	0.84%
May 1, 2024	284.80M	4.55%
Apr 30, 2024	272.40M	-0.22%
Apr 29, 2024	273.00M	-0.47%
Apr 26, 2024	274.30M	2.54%
Apr 25, 2024	267.50M	-1.58%
Apr 24, 2024	271.80M	-
Apr 23, 2024	271.80M	0.22%
Apr 22, 2024	271.20M	-2.66%
Apr 19, 2024	278.60M	-1.52%
Apr 18, 2024	282.90M	-1.50%
Apr 17, 2024	287.20M	-4.14%
Apr 16, 2024	299.60M	2.99%
Apr 15, 2024	290.90M	-8.38%

View and export this data all the way back to 2020. Sign Up Today.

Related Stocks

Company	Market Cap
Actinium Pharmaceuticals	289.33M
Nyxoah	288.34M
Verastem	288.08M
Invivyd	287.55M
Atai Life Sciences	286.28M
Aquestive Therapeutics	284.50M
Adaptimmune Therapeutics	283.60M
23andMe Holding Co.	281.83M